KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity

Virology

Volumn 351, Issue 1, 2006, Pages 18-28

  Bajaj, Bharat G ^a   Verma, Subhash C ^a   Lan, Ke ^a   Cotter, Murray A ^a   Woodman, Zenda L ^a   Robertson, Erle S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Kaposi sarcoma; KSHV; LANA; Pim 1

Indexed keywords

ENDOPEPTIDASE LA; LATENCY ASSOCIATED NUCLEAR ANTIGEN;

AMINO TERMINAL SEQUENCE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; GENE MAPPING; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; UPREGULATION; VIRUS CARCINOGENESIS;

ANTIGENS, VIRAL; APOPTOSIS; B-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; EPITHELIAL CELLS; HERPESVIRUS 8, HUMAN; HUMANS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-PIM-1; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; TRANSCRIPTION, GENETIC; UP-REGULATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8;

EID: 33745886845     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.03.037     Document Type: Article

References (64)

1. Aho T.L., Sandholm J., Peltola K.J., Mankonen H.P., Lilly M., and Koskinen P.J. Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett. 571 1-3 (2004) 43-49
2. An J., Sun Y., and Rettig M.B. Transcriptional coactivation of c-Jun by the KSHV-encoded LANA. Blood 103 1 (2004) 222-228
3. Arvanitakis L., Mesri E.A., Nador R.G., Said J.W., Asch A.S., Knowles D.M., and Cesarman E. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 88 7 (1996) 2648-2654
4. Ayala G.E., Dai H., Ittmann M., Li R., Powell M., Frolov A., Wheeler T.M., Thompson T.C., and Rowley D. Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res. 64 17 (2004) 6082-6090
5. Bachmann M., Hennemann H., Xing P.X., Hoffmann I., and Moroy T. The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint. J. Biol. Chem. 279 46 (2004) 48319-48328
6. Ballestas M.E., Chatis P.A., and Kaye K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284 5414 (1999) 641-644
7. Barre B., Avril S., and Coqueret O. Opposite regulation of myc and p21waf1 transcription by STAT3 proteins. J. Biol. Chem. 278 5 (2003) 2990-2996
8. Ben-Bassat H., Goldblum N., Mitrani S., Goldblum T., Yoffey J.M., Cohen M.M., Bentwich Z., Ramot B., Klein E., and Klein G. Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D. G.-75). Int. J. Cancer 19 1 (1977) 27-33
9. Bhattacharya N., Wang Z., Davitt C., McKenzie I.F., Xing P.X., and Magnuson N.S. Pim-1 associates with protein complexes necessary for mitosis. Chromosoma 111 2 (2002) 80-95
10. Borg K.E., Zhang M., Hegge D., Stephen R.L., Buckley D.J., Magnuson N.S., and Buckley A.R. Prolactin regulation of pim-1 expression: positive and negative promoter elements. Endocrinology 140 12 (1999) 5659-5668
11. Cesarman E., Chang Y., Moore P.S., Said J.W., and Knowles D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332 18 (1995) 1186-1191
12. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., and Moore P.S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266 5192 (1994) 1865-1869
13. Cotter II M.A., and Robertson E.S. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264 2 (1999) 254-264
14. Cotter II M.A., and Robertson E.S. Modulation of histone acetyltransferase activity through interaction of 0. Mol. Cell. Biol. 20 15 (2000) 5722-5735
15. Cotter M.A., and Robertson E.S. Molecular biology of Kaposi's sarcoma-associated herpesvirus. Front. Biosci. 7 (2002) d358-d375
16. Cotter II M.A., Subramanian C., and Robertson E.S. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus. Virology 291 2 (2001) 241-259
17. Cuypers H.T., Selten G., Quint W., Zijlstra M., Maandag E.R., Boelens W., van Wezenbeek P., Melief C., and Berns A. Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell 37 1 (1984) 141-150
18. Dai H., Li R., Wheeler T., Diaz de Vivar A., Frolov A., Tahir S., Agoulnik I., Thompson T., Rowley D., and Ayala G. Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer. Prostate 65 3 (2005) 276-286
19. Friborg Jr. J., Kong W., Hottiger M.O., and Nabel G.J. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402 6764 (1999) 889-894
20. Fujimuro M., and Hayward S.D. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta. J. Virol. 77 14 (2003) 8019-8030
21. Fujimuro M., Wu F.Y., ApRhys C., Kajumbula H., Young D.B., Hayward G.S., and Hayward S.D. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med. 9 3 (2003) 300-306
22. Fujimuro M., Liu J., Zhu J., Yokosawa H., and Hayward S.D. Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen. J. Virol. 79 16 (2005) 10429-10441
23. Gaidano G., and Dalla-Favera R. Biologic and molecular characterization of non-Hodgkin's lymphoma. Curr. Opin. Oncol. 5 5 (1993) 776-784
24. Graham F.L., Smiley J., Russell W.C., and Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36 1 (1977) 59-74
25. Grunweller A., Gillen C., Erdmann V.A., and Kurreck J. Cellular uptake and localization of a Cy3-labeled siRNA specific for the serine/threonine kinase Pim-1. Oligonucleotides 13 5 (2003) 345-352
26. Hermouet S., Corre I., Gassin M., Bigot-Corbel E., Sutton C.A., and Casey J.W. Hepatitis C virus, human herpesvirus 8, and the development of plasma-cell leukemia. N. Engl. J. Med. 348 2 (2003) 178-179
27. Hirano T., Ishihara K., and Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19 21 (2000) 2548-2556
28. Hoefnagel J.J., Dijkman R., Basso K., Jansen P.M., Hallermann C., Willemze R., Tensen C.P., and Vermeer M.H. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood 105 9 (2005) 3671-3678
29. Kaaya E., Castanos-Velez E., Heiden T., Ekman M., Catrina A.I., Kitinya J., Andersson L., and Biberfeld P. Proliferation and apoptosis in the evolution of endemic and acquired immunodeficiency syndrome-related Kaposi's sarcoma. Med. Oncol. 17 4 (2000) 325-332
30. Kanno Y., Kozak C.A., Schindler C., Driggers P.H., Ennist D.L., Gleason S.L., Darnell Jr. J.E., and Ozato K. The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds. Mol. Cell. Biol. 13 7 (1993) 3951-3963
31. Katano H., Sato Y., and Sata T. Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies. Cancer 92 12 (2001) 3076-3084
32. Khan K.D., Shuai K., Lindwall G., Maher S.E., Darnell Jr. J.E., and Bothwell A.L. Induction of the Ly-6A/E gene by interferon alpha/beta and gamma requires a DNA element to which a tyrosine-phosphorylated 91-kDa protein binds. Proc. Natl. Acad. Sci. U. S. A. 90 14 (1993) 6806-6810
33. Kim K.T., Baird K., Ahn J.Y., Meltzer P., Lilly M., Levis M., and Small D. Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival. Blood 105 4 (2005) 1759-1767
34. Krithivas A., Young D.B., Liao G., Greene D., and Hayward S.D. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J. Virol. 74 20 (2000) 9637-9645
35. Krithivas A., Fujimuro M., Weidner M., Young D.B., and Hayward S.D. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes. J. Virol. 76 22 (2002) 11596-11604
36. Kruman I., Guo Q., and Mattson M.P. Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J. Neurosci. Res. 51 3 (1998) 293-308
37. Kuppers D.A., Lan K., Knight J.S., and Robertson E.S. Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1. J. Virol. 79 15 (2005) 9714-9724
38. Lan K., Kuppers D.A., Verma S.C., and Robertson E.S. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J. Virol. 78 12 (2004) 6585-6594
39. Lim C., Sohn H., Gwack Y., and Choe J. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. J. Gen. Virol. 81 Pt. 11 (2000) 2645-2652
40. Lim C., Gwack Y., Hwang S., Kim S., and Choe J. The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Biol. Chem. 276 33 (2001) 31016-31022
41. Losman J.A., Chen X.P., Vuong B.Q., Fay S., and Rothman P.B. Protein phosphatase 2A regulates the stability of Pim protein kinases. J. Biol. Chem. 278 7 (2003) 4800-4805
42. Mikkers H., Nawijn M., Allen J., Brouwers C., Verhoeven E., Jonkers J., and Berns A. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol. Cell. Biol. 24 13 (2004) 6104-6115
43. Mikovits J., Ruscetti F., Zhu W., Bagni R., Dorjsuren D., and Shoemaker R. Potential cellular signatures of viral infections in human hematopoietic cells. Dis. Markers 17 3 (2001) 173-178
44. Mochizuki T., Kitanaka C., Noguchi K., Muramatsu T., Asai A., and Kuchino Y. Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J. Biol. Chem. 274 26 (1999) 18659-18666
45. Moore P.S., Boshoff C., Weiss R.A., and Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274 5293 (1996) 1739-1744
46. Narimatsu M., Maeda H., Itoh S., Atsumi T., Ohtani T., Nishida K., Itoh M., Kamimura D., Park S.J., Mizuno K., Miyazaki J., Hibi M., Ishihara K., Nakajima K., and Hirano T. Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells. Mol. Cell. Biol. 21 19 (2001) 6615-6625
47. Palaty C.K., Clark-Lewis I., Leung D., and Pelech S.L. Phosphorylation site substrate specificity determinants for the Pim-1 protooncogene-encoded protein kinase. Biochem. Cell. Biol. 75 2 (1997) 153-162
48. Piolot T., Tramier M., Coppey M., Nicolas J.C., and Marechal V. Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J. Virol. 75 8 (2001) 3948-3959
49. Radkov S.A., Kellam P., and Boshoff C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat. Med. 6 10 (2000) 1121-1127
50. Rahman Z., Yoshikawa H., Nakajima Y., and Tasaka K. Down-regulation of Pim-1 and Bcl-2 is accompanied with apoptosis of interleukin-6-depleted mouse B-cell hybridoma 7TD1 cells. Immunol. Lett. 75 3 (2001) 199-208
51. Rainio E.M., Ahlfors H., Carter K.L., Ruuska M., Matikainen S., Kieff E., and Koskinen P.J. Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity. Virology 333 2 (2005) 201-206
52. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., and Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2 3 (1996) 342-346
53. Renne R., Barry C., Dittmer D., Compitello N., Brown P.O., and Ganem D. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75 1 (2001) 458-468
54. Shay K.P., Wang Z., Xing P.X., McKenzie I.F., and Magnuson N.S. Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway. Mol. Cancer Res. 3 3 (2005) 170-181
55. Si H., and Robertson E.S. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function. J. Virol. 80 2 (2006) 697-709
56. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M.F., Clauvel J.P., Raphael M., Degos L., et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86 4 (1995) 1276-1280
57. van Santen V., Cheung A., and Kieff E. Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line. Proc. Natl. Acad. Sci. U. S. A. 78 3 (1981) 1930-1934
58. Verbeek S., van Lohuizen M., van der Valk M., Domen J., Kraal G., and Berns A. Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally. Mol. Cell. Biol. 11 2 (1991) 1176-1179
59. Verma S.C., Borah S., and Robertson E.S. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1. J. Virol. 78 19 (2004) 10348-10359
60. Verma, S.C., Lan, K., and Robertson, E.S., in press. "Structure and Function of Latency Associated Nuclear Antigen (LANA)." In: Weiss, R., Boshoff, C. (Eds.), Current Topics in Microbiology and Immunology. Springer Verlag.
61. Viejo-Borbolla A., Ottinger M., Bruning E., Burger A., Konig R., Kati E., Sheldon J.A., and Schulz T.F. Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J. Virol. 79 21 (2005) 13618-13629
62. Wang Z., Bhattacharya N., Mixter P.F., Wei W., Sedivy J., and Magnuson N.S. Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase. Biochim. Biophys. Acta 1593 1 (2002) 45-55
63. Yan B., Zemskova M., Holder S., Chin V., Kraft A., Koskinen P.J., and Lilly M. The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. J. Biol. Chem. 278 46 (2003) 45358-45367
64. Yip-Schneider M.T., Horie M., and Broxmeyer H.E. Transcriptional induction of pim-1 protein kinase gene expression by interferon gamma and posttranscriptional effects on costimulation with steel factor. Blood 85 12 (1995) 3494-3502